Maia Szalavitz

The Trump administration is going after harm reduction.

States are rolling back coverage for lifesaving medications.

Harm reduction is losing funding. Can it survive?

Shaming people for being on medication is dangerous.

Is a powerful addiction treatment already invented?

The Trump administration misunderstands autism and what autistic people and our families need.

Hay más de una manera de recuperarse de una adicción.

There’s no single way to achieve addiction recovery.

Talking to a chatbot may have some benefits — if it doesn’t lead to a full-blown addiction.

The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health crisis.

America can’t go backward on drug policy.

Drug overdose deaths are finally declining. But it’s going to take work to keep this trend going.

Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating addiction.

The drug has swept across the country and brought a massive wave of overdose deaths in its wake.

A misunderstanding of brain chemistry and neural circuitry has made people believe they should avoid pleasure.

We need a safer, kinder and more effective approach to treating troubled teenagers.

How harm reduction can work in a red state.

Rescheduling the drug is the beginning of the end of marijuana criminalization. Now we need to think about regulation.

A number of new tech companies want to solve the opioid crisis with algorithms. It’s a flawed and potentially harmful proposition.

Though moral hazard is a powerful concept for thinking about risk in economics, it’s a flawed approach to designing drug policy.